Ovid Therapeutics Inc. (OVID) Tops Q2 EPS by 2c

Ovid Therapeutics Inc. (NASDAQ: OVID) reported Q2 EPS of ($0.18), $0.02 better than the analyst estimate of ($0.20).

For earnings history and earnings-related data on Ovid Therapeutics Inc. (OVID) click here.

You May Also Be Interested In

• Ovid Therapeutics Inc (OVID) PT Raised to $5 at H.C. Wainwright
• UBS Reiterates Buy Rating on Darden Restaurants (DRI) Ahead of Q1 Earnings
• Jersey Mike's Subs (JMKE) PT Raised to $30 at Tigress Financial Partners